参考文献_心脏病学实践.2020·第六分册：心血管综合问题与相关疾病-QQ阅读男生玄幻网

上QQ阅读APP看本书，新人免费读10天

设备和账号都新为新人

参考文献

［1] RAPSOMANIKI E，THURESSON M，YANG E，et al. Using big data from health records from four countries to evaluate chronic disease outcomes：a study in 114 364 survivors of myocardial infarction［J］. Eur Heart J Qual Care Clin Outcomes，2016，2（3）：172-183.

［2] ABTAN J，BHATT D L，ELBEZ Y，et al. Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease：Insights from the REACH Registry［J］. Clin Cardiol，2017，40（9）：710-718.

［3] DUCROCQ G，BHATT D L，LABREUCHE J，et al. Geographic differences in outcomes in outpatients with established atherothrombotic disease：results from the REACH Registry［J］. Eur J Prev Cardiol，2014，21（12）：1509-1516.

［4] BHATT D L，EAGLE K A，OHMAN E M，et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis［J］. JAMA，2010，304（12）：1350-1357.

［5] MUKHERJEE D，EAGLE K A，KLINE-ROGERS E，et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies（from the Global Registry of Acute Coronary Events）［J］.Am J Cardiol，2007，100（1）：1-6.

［6] 徐燕军，赵俊功 . 周围血管疾病合并冠心病的研究进展［J］. 介入放射学杂志， 2016，25（1）：85-88.

［7] PIEPOLI M F，HOES A W，AGEWALL S，et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice：The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice（constituted by representatives of 10 societies and by invited experts）Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation（EACPR）［J］. Eur Heart J，2016，37（29）：2315-2381.

［8] ABOYANS V，RICCO J B，BARTELINK M E L，et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases，in collaboration with the European Society for Vascular Surgery（ESVS）：Document covering atherosclerotic disease of extracranial carotid and vertebral，mesenteric，renal，upper and lower extremity arteriesEndorsed by：the European Stroke Organization（ESO）The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology（ESC）and of the European Society for Vascular Surgery（ESVS）［J］. Eur Heart J，2018，39（9）：763-816.

［9] BAUERSACHS R，ZEYMER U，BRIÈRE J B，et al. Burden of Coronary Artery Disease and Peripheral Artery Disease：A Literature Review［J］. Cardiovasc Ther，2019，2019：8295054.

［10] FERGUSON J J，GONZALEZ E R，KANNEL W B，et al. Clinical safety and efficacy of clopidogrel--implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events（CAPRIE）study for future management of atherosclerotic disease［J］. Clin Ther，1998，20 Suppl B：B42-B53.

［11] ALEXANDER J H，LOPES R D，JAMES S，et al. Apixaban with antiplatelet therapy after acute coronary syndrome［J］. N Engl J Med，2011，365（8）：699-708.

［12] MEGA J L，BRAUNWALD E，WIVIOTT S D，et al. Rivaroxaban in patients with a recent acute coronary syndrome［J］. N Engl J Med，2012，366（1）：9-19.

［13] EIKELBOOM J W，CONNOLLY S J，BOSCH J，et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease［J］. N Engl J Med，2017，377（14）：1319-1330.

［14] MACKMAN N，SPRONK H M H，STOUFFER G A，et al. Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients［J］. Arterioscler Thromb Vasc Biol，2018，38（4）：726-732.

［15] COLLISON T，SMITH J M，ENGEL A M. Peripheral vascular disease and outcomes following coronary artery bypass graft surgery［J］. Arch Surg，2006，141（12）：1214-1218； discussion 1219.

［16] NORGREN L，HIATT W R，DORMANDY J A，et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease（TASC Ⅱ）［J］. Eur J Vasc Endovasc Surg，2007，33 Suppl 1：S1-S75.

［17] MCFALLS E O，WARD H B，MORITZ T E，et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease：results of the CARP trial［J］. Eur Heart J，2008，29（3）：394-401.

［18] FERKET B S，SPRONK S，COLKESEN E B，et al. Systematic review of guidelines on peripheral artery disease screening［J］.Am J Med，2012，125（2）：198-208.e3.

［19] COLLET J P，CAYLA G，ENNEZAT P V，et al. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease：The randomized AMERICA Study［J］. Int J Cardiol，2018，254：36-42.

［20] GERHARD-HERMAN M D，GORNIK H L，BARRETT C，et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease：executive summary：a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines［J］. J Am Coll Cardiol，2017，69（11）：1465-1508.

［21] ABOYANS V，RICCO J B，BARTELINK M E L，et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases，in collaboration with the European Society for Vascular Surgery（ESVS）：document covering atherosclerotic disease of extracranial carotid and vertebral，mesenteric，renal，upper and lower extremity arteries［J］. Eur Heart J，2018，39（9）：763-816.